NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

AMAG - AMAG Pharmaceuticals Inc

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (IDA). The Company markets and sells Feraheme in the United States through its own commercial organization. Feraheme is approved for use in the treatment of both dialysis and non-dialysis dependent chronic kidney disease (CKD) patients. I","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# AMAGhart

AMAG Pharmaceuticals Inc News


Market Wrap-up: GAP, FB, ARO, CAT, HPQ, BRK.A, CP in Focus
ValueWalk - May 17, 2012
By Abhijit Sen Every afternoon we provide an update on global market levels, economic news, and hedge fund news. US markets end lower: US markets closed lower on Thursday, extending their losses in the final hour of trading, on disappointing economic ...

Ladenburg Thalmann Upgrades AMAG Pharmaceuticals to Buy (AMAG)
Junction Report - May 17, 2012
AMAG Pharmaceuticals (NASDAQ: AMAG) was upgraded by analysts at Ladenburg Thalmann from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Thursday.
UPDATE: Ladenburg Thalmann Upgrades AMAG Pharmaceuticals to Buy - Benzinga
AMAG Pharma (AMAG) Shares Rally Sharply Following Ladenburg Upgrade - StreetInsider.com (subscription)

Stock Analysts' Upgrades for May, 17th (ABGLY, ACHC, AMAG, ATO, BBVA, CHKM, CP ...
Junction Report - May 17, 2012
AFRICAN BARRICK GOLD (NASDAQ: ABGLY) was upgraded by analysts at Goldman Sachs from a “sell” rating to a “neutral” rating.

AMAG Appoints William Heiden as President and CEO
Renal Business Today - May 16, 2012
LEXINGTON, Mass.—AMAG Pharmaceuticals, Inc., announced the appointment of William K. Heiden as president and chief executive officer.

Investment Analysts' Ratings Reiterations for May, 11st (AFL, AMAG, ARNA, AWK ...
Junction Report - May 12, 2012
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) had its “neutral” rating re-affirmed by analysts at Goldman Sachs. Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) had its “hold” rating re-affirmed by analysts at Needham & Company.

AMAG Pharmaceuticals Rating Lowered to Neutral at Ladenburg Thalmann (AMAG)
Daily Political - May 11, 2012
AMAG Pharmaceuticals (NASDAQ: AMAG) was downgraded by research analysts at Ladenburg Thalmann from a “buy” rating to a “neutral” rating in a report released on Thursday.
UPDATE: Ladenburg Thalmann Downgrades AMAG Pharmaceuticals; Removes PT - Benzinga

US HOT STOCKS: JPMorgan, McDermott, Brooks Active In Late Trading
Wall Street Journal - May 10, 2012
US stocks were mixed Thursday as the Dow Jones Industrial Average added 20 points to 12855 and the Standard & Poor's 500-stock index gained 3.4 points to 1358, while the Nasdaq Composite slipped 1.1 points to 2934.

Nasdaq stocks posting largest volume increases
BusinessWeek - May 10, 2012
AMAG Pharmaceuticals Inc. : Approximately 1392100 shares changed hands, a 1145.1 percent increase over its 65-day average volume. The shares fell $2.35 or 14.7 percent to $13.67.

Nasdaq stocks posting largest percentage decreases
CBS News - May 10, 2012
NEW YORK - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Silicon Graphics International Corp. fell 32.1 percent to $6.17.

Table of Unusual NASDAQ Stock Moves From RealTick
Wall Street Journal - May 10, 2012
REALTICK LIST OF MOST UNUSUALLY TRADED STOCKS DATE: 05/10/2012 COUNTRY: US EXCHANGE: NASDAQ TIME PERIOD: 9:30 - 3:20 LAST CHANGE %CHANGE RANK COMPANY NAME TICKER PRICE ON DAY ON DAY 1 REPROS THERAPEUTICS RPRX 5.27 1.09 25.96 2 CELL THERAPEUTICS IN CTIC ...

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>